Author | Conference | Journal | Organization | Year | DOI
Look for results that meet for the following criteria:
Academic
Publications
Clinical Experience with Therapeutic Vaccines Designed for Patients with Hepatitis

Clinical Experience with Therapeutic Vaccines Designed for Patients with Hepatitis,10.2174/138161209787846793,Current Pharmaceutical Design,Dendev Bat

Edit
Clinical Experience with Therapeutic Vaccines Designed for Patients with Hepatitis   (Citations: 4)
BibTex | RIS | RefWorks Download
Journal: Current Pharmaceutical Design - CURR PHARM DESIGN , vol. 15, no. 11, pp. 1159-1171, 2009
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
    • ...Oral therapeutic vaccine V5 was originally developed for the management of chronic hepatitis B and C [4-6]...
    • ...The preparation is derived from pooled blood of HBVand HCV-positive donors, which following chemicaland heat inactivation was formulated into an oral pill according to proprietary technology developed by us [6]...
    • ...There were earlier indications that V5 exhibits the anti-inflammatory activity [4-8]...

    Dmitry A Butov, et al. Phase IIb randomized trial of adjunct immunotherapy in patients with f...

    • ...These studies point toward the phenomenon of immune tolerance - a concept we have adopted for development of oral immunomodulators for autoimmune diseases such as AIDS and viral hepatitis B and C. These immune interventions have shown excellent safety profile and high response rates in several clinical trials we have conducted over the last ten years [57,58]...

    Aldar S Bourinbaiar, et al. Safety and efficacy trial of adipose-tissue derived oral preparation V...

Sort by:

Citations (4)

Share this on